Science Speaks is in Atlanta, Georgia this week and will be live-blogging from the 20th CROI — Conference on Retroviruses and Opportunistic Infections from Sunday to Wednesday, covering breaking developments from investigators on cure research, new antiretroviral agents, hepatitis, tuberculosis and treatment as prevention. ATLANTA, GA — To put this in perspective, about 70 million […]
When Dr. Dan Kuritzkes of Harvard Medical School and Brigham and Women’s Hospital presented his team’s findings on two HIV-positive men who remained on antiretroviral therapy while undergoing stem cell transplants, and in whom the levels of HIV DNA had since dropped to undetectable levels, he was careful to emphasize that he was not claiming […]
HIV
The following is a guest post by Cristina de la Torre, DSc, MPH of MEASURE Evaluation In southern Africa, a large population of young and adolescent […]
Tuberculosis
Medicine represents third choice over “deaf or dead” for many patients, health worker/tuberculosis survivor-founded organization says Praising the treatment policy decision of South Africa health officials […]
Research & Development
Tools to diagnose and monitor HIV, hepatitis B and C, and tuberculosis, as well as resistance to first-line TB treatment are among the tests included in […]
Policy
Brushing aside White House proposals to cut global HIV and other international disease response funding, members of the House Appropriations Labor, Health and Human Services, Education […]